Carl Evans
Equibles does not estimate personal net worth.
About Carl Evans
Carl Evans was last confirmed as Board Member at CNS Pharmaceuticals, Inc. (CNSP) in a filing dated April 10, 2024. CNS Pharmaceuticals, Inc. reported in an 8-K filed February 27, 2024 that Carl Evans was appointed Audit Committee, effective February 21, 2024.
“On February 21, 2024, the Board of Directors of the Company approved the following appointments to its Board committees: (i) Audit Committee – Jeff Keyes (Chair), Carl Evans and Amy Mahery; (ii) Compensation Committee – Dr. Jerzy (George) Gumulka (Chair), Jeff Keyes and Dr. Bettina Cockroft; and (iii) Nominating and Governance Committee – Dr. Bettina Cockroft (Chair) and Faith Charles.”
Affiliation history
-
Start not stated–2024-04-10
Last confirmed by a filing; no departure on record